# Pathogen Blood Testing
Blood testing can add another layer when deeper or systemic fungal involvement is being explored.
### What this page is for
This page helps separate:
* direct detection of fungal material in blood
* immune-response testing
* conventional high-risk fungal testing
* research-oriented or integrative approaches
### NIIM's pathogen blood test approach
The NIIM assay uses a two-part process.
#### Part 1: Direct visualisation
Fresh and processed blood are examined under the microscope for:
* normal white blood cells
* atypical human cells
* non-human cells, including bacteria, fungi, moulds, protozoa, and parasites
#### Part 2: Genetic identification
If non-human forms are seen, the lab can proceed to DNA-based identification.
That may include:
* PCR for bacterial pathogens
* fungal or mould DNA sequencing for species identification
#### Group member experience with NIIM test:
> I did the NIIM CTC and got a clean Step 1 result, which means: no high-burden visible infection on that day's blood draw. It does **not** mean all is clear for Bartonella, chronic Borrelia, low-level Babesia, or even Aspergillus unless Step 2 was actually triggered. And it was not triggered. It's worth noting that with the Step 1 tools Aspergillus detection figures of approx 50% apply to people with active, invasive, symptomatic infection — for someone carrying a low-level, non-invasive, asymptomatic Aspergillus burden (which is far more common in people with compromised immunity), the likelihood of Step 1 microscopy catching it drops close to zero, meaning the ***NIIM testing process would return a clean result while a low-level but still immune suppressing fungal load quietly continues***
### Why is this different?
This is not antibody testing.
It aims to detect the pathogen itself using pretty basic microscopy, and if it finds it, it looks for its DNA rather than your immune response to it. \
\
NOTE: **Bartonella isn't even included in NIIM's Step 2 PCR panel at all** — not because it's rare, but because standard Bartonella PCR performs so poorly on whole blood that it would give false reassurance anyway. Detecting chronic Bartonella requires a specialised enrichment process that only a handful of labs worldwide do well.
### Important distinction
Mainstream medicine treats frank fungemia as a marker of severe invasive disease.
Research assays like NIIM sit in a greyer zone:
* microscopic fungal elements
* circulating fungal DNA
* low-level or subclinical presence *under investigation.*
***
### Conventional fungal blood-testing options
#### Blood culture for fungi
**Best for:** confirmed bloodstream infection.
**Limit:** low sensitivity, especially for *Aspergillus*.
***
#### β-D-glucan
**Detects:** a pan-fungal cell-wall component in serum.
**Useful for:** serial monitoring in higher-risk settings.
**Limit:** not species-specific, with possible false positives.
***
#### Galactomannan
**Detects:** an *Aspergillus* cell-wall antigen.
**Useful for:** invasive aspergillosis workups, especially in high-risk patients.
***
#### Aspergillus PCR
**Detects:** circulating *Aspergillus* DNA.
**Useful for:** faster detection than culture in specialist settings.
Aspergillus PCR in whole blood achieves a sensitivity of 71–86%**.**
***
#### Candida PCR or T2Candida
**Detects:** circulating *Candida* DNA.
**Useful for:** earlier detection than standard culture in some high-risk settings.
***
### Antibody tests are different
Fungal antibody testing looks at the host's immune response.
That can be relevant in some contexts, but it does not prove active invasive infection.
***
### When blood testing is most relevant
Blood testing becomes more relevant when there is concern for:
* deep or systemic burden
* high-risk immunosuppression
* persistent fever despite antibiotics
* lung infiltrates or sino-orbital symptoms
* severe oncology or transplant risk settings
### How blood testing can support the protocol
#### Baseline
Consider fungal testing if clinically indicated, plus:
* ALT and AST
* CBC
* kidney function
#### During protocol
* **Day 10:** liver enzymes
* **Week 4:** CMP and CBC
* Repeat fungal markers if they were abnormal at baseline and your practitioner thinks they are useful for response tracking
### Key takeaways
* Direct detection looks for pathogen or DNA, not antibodies.
* Circulating fungal DNA is real and measurable.
* Standard tests still matter in high-risk settings.
* Species identification can help tailor therapy.
* Negative testing does not always rule out meaningful fungal involvement.
### Selected references
* [NIIM Pathogen Blood Test Research Study](https://niim.com.au/research/pathogen)
* [Pan-cancer fungal ecologies and bacteriome interactions](https://pmc.ncbi.nlm.nih.gov/articles/PMC9567272/)
* [The fungal mycobiome: a new hallmark of cancer](https://www.nature.com/articles/s41392-023-01334-6)
* [Diagnosis of invasive fungal infections: challenges and recent developments](https://pmc.ncbi.nlm.nih.gov/articles/PMC10278348/)
* [β-D-Glucan testing is important for diagnosis of invasive fungal infections](https://pmc.ncbi.nlm.nih.gov/articles/PMC3889722/)
* [Unraveling the fungi-cancer connection](https://spj.science.org/doi/10.34133/research.0931)
{% hint style="warning" %}
Interpret blood-testing results in clinical context. A positive PCR or DNA signal does not automatically prove viable invasive infection.
{% endhint %}
### Explore the anti-fungal guide
Choose any section below.
* [Anti-fungal Protocol Building Support](/myhealingcommunity-docs/fungal-pathogens/anti-fungal-protocol-building-support.md)
* [Key Fungal Players](/myhealingcommunity-docs/fungal-pathogens/anti-fungal-protocol-building-support/key-fungal-players.md)
* [The Problem](/myhealingcommunity-docs/fungal-pathogens/anti-fungal-protocol-building-support/the-problem.md)
* [Core Strategy](/myhealingcommunity-docs/fungal-pathogens/anti-fungal-protocol-building-support/core-strategy.md)
* [Laminarin](/myhealingcommunity-docs/fungal-pathogens/anti-fungal-protocol-building-support/laminarin.md)
* [Usnea Tincture](/myhealingcommunity-docs/fungal-pathogens/anti-fungal-protocol-building-support/usnea-tincture.md)
* [β-Glucanase Enzymes](/myhealingcommunity-docs/fungal-pathogens/anti-fungal-protocol-building-support/v-glucanase-enzymes.md)
* [Antifungal Medication](/myhealingcommunity-docs/fungal-pathogens/anti-fungal-protocol-building-support/antifungal-medication.md)
* [Binders & Detox Support](/myhealingcommunity-docs/fungal-pathogens/anti-fungal-protocol-building-support/binders-and-detox-support.md)
* [Daily Schedule](/myhealingcommunity-docs/fungal-pathogens/anti-fungal-protocol-building-support/daily-schedule.md)
* [Expected Timeline & What to Watch For](/myhealingcommunity-docs/fungal-pathogens/anti-fungal-protocol-building-support/expected-timeline-and-what-to-watch-for.md)
* [Monitoring & Safety Guidelines](/myhealingcommunity-docs/fungal-pathogens/anti-fungal-protocol-building-support/monitoring-and-safety-guidelines.md)
* [Pathogen Blood Testing](/myhealingcommunity-docs/fungal-pathogens/anti-fungal-protocol-building-support/pathogen-blood-testing.md)
* [Stool Testing for Fungal Pathogens](/myhealingcommunity-docs/fungal-pathogens/anti-fungal-protocol-building-support/stool-testing-for-fungal-pathogens.md)
* [Q\&A: Pathogen β-Glucans vs Supplement β-Glucans](/myhealingcommunity-docs/fungal-pathogens/anti-fungal-protocol-building-support/q-and-a-pathogen-v-glucans-vs-supplement-v-glucans.md)
* [Scientific References & Further Reading](/myhealingcommunity-docs/fungal-pathogens/anti-fungal-protocol-building-support/scientific-references-and-further-reading.md)
---
# Agent Instructions: Querying This Documentation
If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question.
Perform an HTTP GET request on the current page URL with the `ask` query parameter:
```
GET https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/fungal-pathogens/anti-fungal-protocol-building-support/pathogen-blood-testing.md?ask=
```
The question should be specific, self-contained, and written in natural language.
The response will contain a direct answer to the question and relevant excerpts and sources from the documentation.
Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.